Filing Flows › Balchem (BCPC) › Q3 2026 › vs Q3 2025
Balchem (BCPC) Q3 2026 vs Q3 2025 (year over year)
Balchem's revenue rose $23.1M (+9%) from $268M in Q3 2025 to $291M in Q3 2026. The biggest changes: Product Sales Revenue +$23.2M (+9%); Royalty Revenue −$79K (-16%). Gross margin 36.4% against 35.7% (+0.7 pts).
Balchem, Q3 2026: revenue $291M (+9% year over year), operating margin 21.5%, net earnings $46.7M, operating cash flow $69.8M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 36.4% | 35.7% | +0.7 pts |
| Operating margin | 21.5% | 20.4% | +1.1 pts |
| Net margin | 16.1% | 15.1% | +1.0 pts |
| Free cash flow margin | 19.9% | 18.9% | +1.0 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Product Sales Revenue | $290M | $267M | $23.2M | +9% |
| Royalty Revenue | $401K | $480K | −$79K | -16% |
| Revenue | $291M | $268M | $23.1M | +9% |
| Gross profit | $106M | $95.5M | $10.3M | +11% |
| Cost of revenue | $185M | $172M | $12.8M | +7% |
| Operating profit | $62.4M | $54.6M | $7.9M | +14% |
| Operating expenses | $43.3M | $40.9M | $2.4M | +6% |
| Pre-tax earnings | $60.0M | $52.0M | $8.0M | +15% |
| Other expense, net | $2.4M | $2.5M | −$142K | -6% |
| Research & development | $5.3M | $4.5M | $847K | +19% |
| Sales & marketing | $20.7M | $19.1M | $1.6M | +8% |
| General & admin | $17.2M | $17.3M | −$42K | -0.2% |
| Net earnings | $46.7M | $40.3M | $6.4M | +16% |
| Income tax | $13.3M | $11.8M | $1.6M | +13% |
| Depreciation & amortization | $12.4M | $11.6M | $837K | +7% |
| Share-based compensation | $5.0M | $4.7M | $389K | +8% |
| Working capital & other | $5.6M | $9.1M | −$3.5M | -38% |
| Operating cash flow | $69.8M | $65.6M | $4.2M | +6% |
| Free cash flow (company-reported) | $57.9M | $50.7M | $7.2M | +14% |
| Capital expenditures and proceeds from the sale of assets | $11.9M | $14.9M | −$3.0M | -20% |
Questions
How much did Balchem's revenue grow year over year in Q3 2026?
Balchem's revenue rose $23.1M (+9%) from $268M in Q3 2025 to $291M in Q3 2026.
What drove Balchem's revenue change in Q3 2026?
Product Sales Revenue +$23.2M (+9%); Royalty Revenue −$79K (-16%).